A FORWARD-THINKING Welsh firm showcased its “revolutionary” non-invasive wearable blood glucose sensor at an international diabetes tech conference last weekend.
Afon Technology, a leading name in cutting-edge medical technology, proudly presented on the international stage during DTechCon (World Congress of Diabetes Technology & Therapeutics) in Kochi, India – a global conference dedicated to the latest developments in the field of diabetes tech.
At the international event, the Monmouthshire-based company highlighted its commitment to developing the world’s first non-invasive blood glucose monitoring device, which is tipped to transform the lives of those with diabetes.
Glucowear™ is Afon Technology’s pain-free continuous blood glucose monitor that is set to make life easier for people with diabetes by removing the need for needles when monitoring blood sugar levels.
Sabih Chaudhry, Afon Technology’s CEO, said: “Our participation at DTechCon last weekend was a remarkable opportunity for us to showcase our revolutionary non-invasive blood glucose device on an international stage.”
“This event provided us with an incredible platform to interact with key opinion leaders, share our innovative technology, and demonstrate our commitment to transforming diabetes management.”
Amit Gupta, one of the founders of Dtech and Secretary of the Society, said: “The recent conference in Kochi was a resounding success, bringing together leading experts and innovators in the field.
“We were privileged to have Afon present their groundbreaking Glucowear technology, which promises to revolutionise diabetes management.”
He added: “Afon Technology is developing Glucowear – a non-invasive, continuous glucose monitoring system that uses radio frequency sensors to provide real-time blood glucose readings without the need for painful finger pricks or invasive procedures.
“This technology will offer significant advantages, including no time lag in results, continuous detection and the ability to monitor glucose levels discreetly via a smartwatch or smartphone. We are hoping that this technology will soon be available in India.”
DTechCon covered various topics, such as mHealth, digital therapeutics, wearable gadgets, non-invasive glucose monitoring, artificial intelligence and machine learning, tele-medicine, connected care, remote monitoring, diabetes reversal and newer drugs.
Afon Technology is a leading innovator in wearable healthcare technology, dedicated to developing cutting-edge solutions that improve patient outcomes and quality of life.
Its device promises to revolutionise blood glucose monitoring, offering a solution that eliminates the pain, discomfort, and other side effects associated with current glucose monitoring options.
For more information, please visit the Afon Technology website.
